Bethany Sensenig
Director at Supernus Pharmaceuticals, Inc. (SUPN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $228K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 23SEC | SUPNSupernus Pharmaceuticals, Inc. | Sell Plan | 1,2173,258 held (−27%) | $50.31 | $61K | -24.7% |
| Feb 23SEC | SUPNSupernus Pharmaceuticals, Inc. | Sell Plan | 3,258 | $51.27 | $167K | -26.1% |
- Sell
Director Bethany Sensenig sold $61K of SUPN at $50.31 — cuts the stake by 27%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Bethany Sensenig sold $167K of SUPN at $51.27 — pre-scheduled 10b5-1 plan sale.